October 13, 2020

Aro Biotherapeutics Appoints Biotechnology Executive Dr. Christopher Mirabelli to its Board of Directors and Nucleic Acid Therapeutics Expert Dr. Masad Damha to its Scientific Advisory Board

October 6, 2020

Aro Collaboration with Ionis Advances with Option Exercise

February 11, 2020

Aro Biotherapeutics Appoints Leading Cancer Biologist Dr. Martin McMahon and Protein Structure and Design Expert Dr. Ronald Swanson to its Scientific Advisory Board

January 9, 2020

Aro Biotherapeutics and Ionis Enter Licensing and Collaboration Agreement Focused on Cell-Specific Delivery of Antisense Oligonucleotides

December 10, 2019

Aro Biotherapeutics Names Seasoned Biopharma Industry Veteran Scott Greenberg as Vice President, Business Development and Alliance Management

October 15, 2019

Aro Biotherapeutics Debuts Lead Centyrin Candidate at 2019 OTS Meeting

May 1, 2019

Aro Biotherapeutics Appoints Anthony Tolcher, MD, to Scientific Advisory Board

April 12, 2019

Aro Biotherapeutics to Present Corporate Overview at BioCentury Future Leader’s In the Biotech Industry Conference

April 2, 2019

Aro Biotherapeutics to Present Data on Lead Program, ABX900, at AACR

December 11, 2018

Aro Biotherapeutics Debuts Lead Centyrin Candidate at 2019 OTS Meeting

December 11, 2018

Aro Biotherapeutics Raises $13 Million and Establishes Leadership Team to Develop Next Generation of Protein Therapeutics